Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease

Sumeet Sharma, Ken Farrington, Robert Kozarski, Christos Christopoulos, Maria Niespialowska-Steuden, Daniel Moffat, Diana Gorog

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Abstract

End-stage renal disease (ESRD) patients have an excess cardiovascular risk, above that predicted by traditional risk factor models. Prothrombotic status may contribute to this increased risk. Global thrombotic status assessment, including
measurement of occlusion time (OT) and thrombolytic status, may identify vulnerable patients. Our aim was to assess overall thrombotic status in ESRD and relate this to cardiovascular risk.
Original languageEnglish
Pages (from-to)354-363
JournalEuropean Heart Journal
Volume34
Issue number5
Early online date9 Oct 2012
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease'. Together they form a unique fingerprint.

Cite this